Abstract
TO THE EDITOR: At first glance, the results of a recent study by Wondergem et al. ([1][1]) may appear discouraging for the evolving science of personalized predictive dosimetry for 90Y radioembolization, especially to less experienced readers. However, the dosimetric implications of their data may
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
